<i> CD146 <sup>+</sup> </i> CAFs mediate immunosuppression in gastric cancer via COL4A1: potential therapeutic targets
Year: 2025
Type: article
Language: en
Topic: Signaling Pathways in Disease
Authors and affiliations:
raw_author_name: Jia Chen
raw_affiliation_strings: Department of General Surgery, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China
Department of General Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Peng Xu
raw_affiliation_strings: Department of General Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Qingyuan Wang
raw_affiliation_strings: Department of General Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Juncheng Dai
raw_affiliation_strings: Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China
State Key Laboratory Cultivation Base of Biomarkers for Cancer Precision Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Shuang Liang
raw_affiliation_strings: Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China
State Key Laboratory Cultivation Base of Biomarkers for Cancer Precision Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Sheng Yang
raw_affiliation_strings: Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China
State Key Laboratory Cultivation Base of Biomarkers for Cancer Precision Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Guiping Xie
raw_affiliation_strings: Department of Surgical Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
raw_author_name: Xiang Li
raw_affiliation_strings: Department of Surgical Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
raw_author_name: Yaohui Wang
raw_affiliation_strings: Department of Pathology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
raw_author_name: Hongjin Hua
raw_affiliation_strings: Department of Pathology, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Xiaochun Ping
raw_affiliation_strings: Department of General Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Jiajia Shen
raw_affiliation_strings: Department of General Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
raw_author_name: Lizong Shen
raw_affiliation_strings: Department of General Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China